Canadian Digestive Health Foundation Public Impact Series 5: Pancreatitis in Canada. Incidence, prevalence, and direct and indirect economic impact.

The Canadian Digestive Health Foundation initiated a scientific program to assess the incidence, prevalence, mortality and economic impact of digestive disorders across Canada in 2009. The current article presents the updated findings from the study concerning pancreatitis.

• Publication year

  2012

• Venue

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie

• Publication date

  2012-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1155/2012/384787PMID 22891180PMCID PMC3378282
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incidence, Prevalence, and Survival of Chronic Pancreatitis: A Population-Based Study

  2011cited by this paper
• The epidemiology and socioeconomic impact of chronic pancreatitis.

  2010cited by this paper
• The prevalence of celiac disease in Europe: Results of a centralized, international mass screening project

  2010cited by this paper
• Update in Acute Pancreatitis

  2010cited by this paper
• Natural History of Acute Pancreatitis: A Long-Term Population-Based Study

  2009cited by this paper
• Population-based study からみた神経予後不良因子の検討

  2009influential reference
• Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases.

  2009cited by this paper
• Gluten-free and regular foods: a cost comparison.

  2008cited by this paper
• Pearls and pitfalls in the diagnosis of adult celiac disease.

  2008cited by this paper
• Epidemiology, aetiology and outcome of acute and chronic pancreatitis: An update.

  2008cited by this paper
• Emerging new clinical patterns in the presentation of celiac disease.

  2008cited by this paper
• Long-term follow-up of individuals with celiac disease: an evaluation of current practice guidelines.

  2007cited by this paper
• Direct Medical Costs of Acute Pancreatitis Hospitalizations in the United States

  2007cited by this paper
• Ninety Percent of Celiac Disease Is Being Missed

  2007cited by this paper
• Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study

  2007cited by this paper
• Increasing prevalence of coeliac disease over time

  2007cited by this paper
• The Incidence and Case-fatality Rates of Acute Biliary, Alcoholic, and Idiopathic Pancreatitis in California, 1994-2001

  2006cited by this paper
• Practice Guidelines in Acute Pancreatitis

  2006cited by this paper
• Practice guidelines in acute pancreatitis.

  2006cited by this paper
• Overweight in Celiac Disease: Prevalence, Clinical Characteristics, and Effect of a Gluten-Free Diet

  2006cited by this paper
• The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review.

  2005cited by this paper
• Factors Associated with Health-Related Quality of Life in Chronic Pancreatitis

  2004cited by this paper
• A prospective study of the incidence of childhood celiac disease.

  2003cited by this paper
• A primary care cross-sectional study of undiagnosed adult coeliac disease

  2003cited by this paper
• High prevalence of celiac disease in patients with type 1 diabetes detected by antibodies to endomysium and tissue transglutaminase.

  2001cited by this paper
• Chronic pancreatitis.

  1995cited by this paper
• Revised classification of pancreatitis

  1985cited by this paper
• Revised classification of pancreatitis—Marseille 1984

  1985cited by this paper

• Epidemiology, etiopathogenesis, immune response, diagnosis, and complications of acute pancreatitis: current insights

  2025influential citation
• Assessing the therapeutic potential of Tirzepatide in modulating inflammatory responses and mitigating acute pancreatitis

  2025cites this paper
• Gluten-Free Product Recalls and Their Impact on Consumer Trust

  2023cites this paper
• Point-of-Care Tests for Pancreatitis

  2023cites this paper
• Acute pancreatitis and its association with dyslipidemia

  2022cites this paper
• Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort Study

  2021cites this paper
• Separating the Empirical Wheat From the Pseudoscientific Chaff: A Critical Review of the Literature Surrounding Glyphosate, Dysbiosis and Wheat-Sensitivity

  2020cites this paper
• High Prevalence of Intraductal Papillary Mucinous Neoplasms in Type 2 Diabetes Mellitus Patients.

  2020cites this paper
• A Drug-Induced Acute Pancreatitis Retrospective Study

  2020cites this paper
• Hospitalizations for Acute and Chronic Pancreatitis in a French-Canadian Population.

  2020cites this paper
• Economic Burden of Not Complying with Canadian Food Recommendations in 2018

  2019cites this paper
• Quality of Life in People with Coeliac Disease: Psychological and Socio- Economic Aspects.

  2019cites this paper
• Epidemiology and Etiology of Acute Pancreatitis in Urban and Suburban Areas in Shanghai: A Retrospective Study

  2018cites this paper
• Diagnosis and management of pancreatic exocrine insufficiency (PEI) in primary care: consensus guidance of a Canadian expert panel

  2018cites this paper
• Estimación de costos directos e indirectos de la pancreatitis aguda en el Hospital San Juan de Lurigancho en el 2015

  2018cites this paper
• HLA‐DQA1‐HLA‐DRB1 polymorphism is a major predictor of azathioprine‐induced pancreatitis in patients with inflammatory bowel disease

  2018cites this paper
• Lipase or amylase for the diagnosis of acute pancreatitis?

  2017cites this paper
• AGY, a Novel Egg Yolk-Derived Anti-gliadin Antibody, Is Safe for Patients with Celiac Disease

  2017cites this paper
• Compliance with Evidence-Based Guidelines in Acute Pancreatitis: an Audit of Practices in University of Toronto Hospitals

  2016cites this paper
• Direct Costs in Patients with Celiac Disease in the USA: A Retrospective Claims Analysis

  2016cites this paper
• Antioxidant therapy in acute, chronic and post-endoscopic retrograde cholangiopancreatography pancreatitis: An updated systematic review and meta-analysis.

  2015cites this paper
• Identification de biomarqueurs de risque à la pancréatite aigüe récurrente dans l’hyperchylomicronémie familiale

  2015cites this paper
• Overview of biomarkers for diagnosis and monitoring of celiac disease.

  2015cites this paper
• Case report: furosemide and pancreatitis: Importance of dose and latency period before reaction.

  2013cites this paper
• Innovation and Best Practices in Endoscopy

  2013cites this paper